CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection.
HIV-induced AIDS may be mediated by the activation of immunosuppressive CD4+CD25+ T regulatory cells (Treg cells). Treg cells have been shown to regulate CD4+ and CD8+ immune responses to HIV and FIV antigens in vitro. We tested the hypothesis that Treg cells become infected and activated during the acute infection with FIV leading to the suppression of CD4+ T helper cell responses. Cats were experimentally infected with FIV-NCSU1 and blood and lymph node cells were collected at weekly intervals following inoculation. Real-time RT-PCR was used to determine plasma viremia and the relative expression of FIV, FoxP3, TGF-beta, and GAPDH mRNA copies in CD4+CD25+ and CD4+CD25- T cell subsets. Flow cytometry was used to assess the absolute numbers of each cell type and the expression of surface TGF-beta and intracellular FoxP3 in CD4+CD25+ and CD4+CD25- T cells at each time-point. Treg suppression of IL-2 production in CD4+ T helper cells was assessed by ELISPOT assays. Our results showed that peak viremia occurred at 2 weeks post infection and correlated with maximal infectivity in CD4+CD25+ T cell populations. FIV-gag-mRNA levels were higher in CD4+CD25+ T cells than CD4+CD25- T cells throughout the acute phase of infection. Induction of FoxP3 and TGF-beta indicated activation of Treg cells during the acute stage infection, which was confirmed by Treg cell suppression of IL-2 production by CD4+ Th cells in an ELISPOT assay. Our findings support the hypothesis that early activation of Treg immunosuppressor function may limit an effective anti-FIV response, contributing to the establishment of chronic infection and the immunodeficiency caused by this virus.
Mexas
Angela M
AM
Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606, United States.
Fogle
Jonathan E
JE
Tompkins
Wayne A
WA
Tompkins
Mary B
MB
D000818:Animals; D002371:Cat Diseases / Q000276:immunology*; D002415:Cats; D016181:Feline Acquired Immunodeficiency Syndrome / Q000276:immunology*; D005434:Flow Cytometry / Q000662:veterinary; D051858:Forkhead Transcription Factors / Q000378:metabolism; D005786:Gene Expression Regulation / Q000276:immunology*; D016089:Immunodeficiency Virus, Feline / Q000235:genetics / Q000276:immunology*; D007376:Interleukin-2 / Q000276:immunology; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D050378:T-Lymphocytes, Regulatory / Q000821:virology*; D014766:Viremia / Q000662:veterinary
D051858:Forkhead Transcription Factors; D007376:Interleukin-2
Eur J Immunol. 2005 Jan;35(1):159-70
15580653
J Infect Dis. 1994 Sep;170(3):543-52
8077711
J Infect Dis. 1998 Aug;178(2):503-11
9697733
J Virol. 1996 Apr;70(4):2474-80
8642675
J Exp Med. 2004 Aug 2;200(3):331-43
15280419
J Virol. 2004 Mar;78(5):2454-9
14963140
Vet Immunol Immunopathol. 2005 Oct 18;108(1-2):219-25
16126280
Am J Pathol. 1993 Nov;143(5):1486-97
8238262
J Virol. 2006 Mar;80(6):3088-91
16501119
Virology. 2004 Apr 10;321(2):307-22
15051390
AIDS. 1990 Dec;4(12):1213-8
1982410
J Immunol. 2004 May 1;172(9):5149-53
15100250
J Immunol. 2005 Mar 15;174(6):3143-7
15749840
J Neurovirol. 2006 Aug;12(4):294-306
16966220
Anal Biochem. 1999 May 15;270(1):41-9
10328763
J Immunol. 2004 Apr 15;172(8):4752-61
15067051
J Clin Invest. 2005 Apr;115(4):1082-91
15761496
J Infect Dis. 2006 Mar 1;193(5):703-12
16453267
J Clin Invest. 2003 Nov;112(9):1437-43
14597769
J Virol. 1987 Jun;61(6):2017-23
3033328
J Virol. 2005 Apr;79(8):4965-76
15795282
J Virol. 1993 Sep;67(9):5175-86
7688819
J Clin Invest. 1989 Dec;84(6):1892-9
2574188
J Immunol. 2004 Jun 1;172(11):6519-23
15153463
J Immunol. 2004 Dec 1;173(11):6526-31
15557141
J Immunol. 2006 Mar 15;176(6):3321-9
16517699
J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):148-60
18091047
J Immunol. 2004 Aug 15;173(4):2211-5
15294929
J Exp Med. 1992 Jun 1;175(6):1589-99
1588283
J Immunol Methods. 2008 Jan 1;329(1-2):81-91
17980384
J Immunol. 2004 Jan 15;172(2):834-42
14707053
J Infect Dis. 1987 Aug;156(2):374-6
3474301
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Immunology. 2006 Aug;118(4):438-48
16762029
J Immunol. 2004 Jun 15;172(12):7832-40
15187167
J Immunol. 2005 Dec 1;175(11):7274-80
16301632
J Exp Med. 2001 Sep 3;194(5):629-44
11535631
Annu Rev Immunol. 2006;24:99-146
16551245